Global Behcet's Disease Therapeutics Market 2022-2026

Published: June 3, 2022 |

TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Description
Table of Contents
List of Tables

Add to Compare

Technavio has been monitoring the Behcet's disease therapeutics market and it is poised to grow by $ 281.72 mn during 2022-2026, decelerating at a CAGR of 6.68% during the forecast period. Our report on the Behcet's disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by heavy use of off-label drugs, special drug designations, and increasing research funding for rare diseases.

Behcet's disease therapeutics market analysis includes product segment and geographic landscape.

Technavio's Behcet's disease therapeutics market is segmented as below:

By Product

Small molecules
Biologics

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing awareness of rare diseases as one of the prime reasons driving the Behcet's disease therapeutics market growth during the next few years. Also, strategic alliances and the advent of novel therapeutics will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on Behcet's disease therapeutics market covers the following areas:

Behcet's disease therapeutics market sizing
Behcet's disease therapeutics market forecast
Behcet's disease therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Behcet's disease therapeutics market vendors that include AbbVie Inc., Amgen Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson, Mitsubishi Chemical Holdings Corp., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Viatris Inc. Also, Behcet's disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73638

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments
Exhibit 24: Chart on Product - Market share 2021-2026 (%)
Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
5.2 Comparison by Product
Exhibit 26: Chart on Comparison by Product
Exhibit 27: Data Table on Comparison by Product
5.3 Small molecules - Market size and forecast 2021-2026
Exhibit 28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
5.4 Biologics - Market size and forecast 2021-2026
Exhibit 32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Product
Exhibit 36: Market opportunity by Product ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Canada - Market size and forecast 2021-2026
Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 France - Market size and forecast 2021-2026
Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
7.13 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 89: AbbVie Inc. - Overview
Exhibit 90: AbbVie Inc. - Product / Service
Exhibit 91: AbbVie Inc. - Key offerings
10.4 Amgen Inc.
Exhibit 92: Amgen Inc. - Overview
Exhibit 93: Amgen Inc. - Product / Service
Exhibit 94: Amgen Inc. - Key offerings
10.5 F. Hoffmann La Roche Ltd.
Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
10.6 Johnson and Johnson
Exhibit 100: Johnson and Johnson - Overview
Exhibit 101: Johnson and Johnson - Business segments
Exhibit 102: Johnson and Johnson - Key news
Exhibit 103: Johnson and Johnson - Key offerings
Exhibit 104: Johnson and Johnson - Segment focus
10.7 Mitsubishi Chemical Holdings Corp.
Exhibit 105: Mitsubishi Chemical Holdings Corp. - Overview
Exhibit 106: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibit 107: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibit 108: Mitsubishi Chemical Holdings Corp. - Segment focus
10.8 Novartis AG
Exhibit 109: Novartis AG - Overview
Exhibit 110: Novartis AG - Business segments
Exhibit 111: Novartis AG - Key offerings
Exhibit 112: Novartis AG - Segment focus
10.9 Pfizer Inc.
Exhibit 113: Pfizer Inc. - Overview
Exhibit 114: Pfizer Inc. - Product / Service
Exhibit 115: Pfizer Inc. - Key news
Exhibit 116: Pfizer Inc. - Key offerings
10.10 Takeda Pharmaceutical Co. Ltd.
Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 118: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 119: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Key offerings
10.11 Viatris Inc.
Exhibit 121: Viatris Inc. - Overview
Exhibit 122: Viatris Inc. - Business segments
Exhibit 123: Viatris Inc. - Key offerings
Exhibit 124: Viatris Inc. - Segment focus

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 125: Inclusions checklist
Exhibit 126: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 127: Currency conversion rates for US$
11.4 Research methodology
Exhibit 128: Research methodology
Exhibit 129: Validation techniques employed for market sizing
Exhibit 130: Information sources
11.5 List of abbreviations
Exhibit 131: List of abbreviations

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Small molecules - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Small molecules - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Biologics - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Biologics - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Product ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Japan - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: AbbVie Inc. - Overview
Exhibits90: AbbVie Inc. - Product / Service
Exhibits91: AbbVie Inc. - Key offerings
Exhibits92: Amgen Inc. - Overview
Exhibits93: Amgen Inc. - Product / Service
Exhibits94: Amgen Inc. - Key offerings
Exhibits95: F. Hoffmann La Roche Ltd. - Overview
Exhibits96: F. Hoffmann La Roche Ltd. - Business segments
Exhibits97: F. Hoffmann La Roche Ltd. - Key news
Exhibits98: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits99: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits100: Johnson and Johnson - Overview
Exhibits101: Johnson and Johnson - Business segments
Exhibits102: Johnson and Johnson - Key news
Exhibits103: Johnson and Johnson - Key offerings
Exhibits104: Johnson and Johnson - Segment focus
Exhibits105: Mitsubishi Chemical Holdings Corp. - Overview
Exhibits106: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibits107: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibits108: Mitsubishi Chemical Holdings Corp. - Segment focus
Exhibits109: Novartis AG - Overview
Exhibits110: Novartis AG - Business segments
Exhibits111: Novartis AG - Key offerings
Exhibits112: Novartis AG - Segment focus
Exhibits113: Pfizer Inc. - Overview
Exhibits114: Pfizer Inc. - Product / Service
Exhibits115: Pfizer Inc. - Key news
Exhibits116: Pfizer Inc. - Key offerings
Exhibits117: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits118: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits119: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits120: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits121: Viatris Inc. - Overview
Exhibits122: Viatris Inc. - Business segments
Exhibits123: Viatris Inc. - Key offerings
Exhibits124: Viatris Inc. - Segment focus
Exhibits125: Inclusions checklist
Exhibits126: Exclusions checklist
Exhibits127: Currency conversion rates for US$
Exhibits128: Research methodology
Exhibits129: Validation techniques employed for market sizing
Exhibits130: Information sources
Exhibits131: List of abbreviations